As of Q2'26 (2025-12-31), Procter & Gamble's diluted EPS stands at 1.78 USD, reflecting a year-over-year decline of -5.3%. This marks a decrease from the previous quarter's EPS of 1.95 USD. Over the period from Q3'23 to Q2'26, the company's diluted EPS has exhibited moderate volatility, with notable peaks in Q1'24 (1.83 USD), Q2'25 (1.88 USD), and Q1'26 (1.95 USD). Year-over-year EPS growth rates have fluctuated, showing both positive and negative quarters, including strong growth in Q2'25 (34.3%) and Q1'26 (21.1%), but also declines in Q2'24, Q4'24, Q1'25, and Q2'26. This pattern suggests a generally upward trend with intermittent periods of contraction, highlighting the cyclical nature of the company's earnings performance over the observed timeframe.